Connecticut 2019 Regular Session

Connecticut House Bill HB07363

Introduced
3/13/19  
Refer
3/13/19  
Refer
3/13/19  
Report Pass
3/25/19  
Report Pass
3/25/19  
Refer
4/5/19  
Refer
4/5/19  
Report Pass
4/11/19  
Report Pass
4/11/19  
Engrossed
6/5/19  
Engrossed
6/5/19  
Report Pass
6/5/19  
Report Pass
6/5/19  
Chaptered
6/26/19  
Chaptered
6/26/19  
Enrolled
6/28/19  
Enrolled
6/28/19  

Caption

An Act Prohibiting Certain Recoupment Provisions In Pharmacy Services Contracts And Concerning A Prevailing Rate Of Wages Exemption.

Impact

The bill has significant implications for state laws regarding pharmacy services and labor agreements. By repealing certain provisions of existing statutes, it enhances pharmacists' ability to communicate crucial cost-information to consumers, which could lead to lower medication costs and increased consumer awareness. Additionally, it affects the prevailing wage laws for public construction projects, ensuring that wages are in accordance with local standards, thereby safeguarding workers' rights and fair pay.

Summary

House Bill 7363, known as 'An Act Prohibiting Certain Recoupment Provisions In Pharmacy Services Contracts And Concerning A Prevailing Rate Of Wages Exemption,' aims to regulate the contractual relationships between pharmacies and health carriers or pharmacy benefits managers. The bill seeks to prohibit contracts from including provisions that prevent pharmacists from disclosing medication costs or alternative treatment options to consumers. It emphasizes transparency in pharmacy services and protects pharmacists from punitive actions related to sharing cost information with patients.

Sentiment

The sentiment surrounding HB 7363 appears largely positive among pharmacy advocates and consumer protection groups who see it as a beneficial reform. They argue that the transparency it brings will lead to better health outcomes for patients and lessen the financial pressures associated with high medication costs. However, there may be concerns among health insurers and pharmacy benefits managers about the potential impact on their financial structures and operating procedures.

Contention

Notable points of contention include the balance between regulatory oversight and the operational freedoms of pharmacies and health insurers. Some stakeholders have raised concerns that the prohibition of recoupment provisions may negatively affect the profitability of pharmacy benefits managers. This bill represents a shift toward increased consumer protections, yet it raises questions about how these changes will affect the existing dynamics within the pharmacy benefits landscape.

Companion Bills

No companion bills found.

Previously Filed As

CT HB05376

An Act Concerning Home Improvement Contractors And Salespersons.

CT HB05495

An Act Making Technical Revisions To Provisions Concerning State Contracting.

CT HB05151

An Act Concerning Solar Licensing Exemptions.

CT SB00389

An Act Concerning The State Contracting Standards Board And State Procurement.

CT HB05170

An Act Concerning Training For Members And Employees Of Inland Wetlands Agencies.

CT HB05475

An Act Concerning The Development Of Housing, Challenges To Certain Decisions Of Municipal Agencies, And The Conversion Of Vacant Nursing Homes Into Multifamily Housing.

CT HB05492

An Act Establishing A Farm Investment Tax Credit And Concerning The Threshold For Certain Optional Farm-related Property Tax Exemptions.

CT HB05392

An Act Exempting Certain Vacant Lots From Conformance With Changes In Zoning Regulations.

CT HB05373

An Act Concerning Various Revisions To Human Services Statutes.

CT HB05477

An Act Concerning Penalties For Blight Upon Real Property, Municipal Agreements To Fix Assessments And A Personal Property Tax Exemption.

Similar Bills

NM HB33

Prescription Drug Price Transparency Act

LA SB271

Provides for medical marijuana. (See Act) (RE1 SEE FISC NOTE GF EX See Note)

CA SB41

Pharmacy benefits.

LA SB143

Enacts Alison Neustrom Act and provides relative to prescribed marijuana for therapeutic uses and the development of rules and regulations by the Louisiana Board of Pharmacy and the Louisiana State Board of Medical Examiners. (gov sig)

MN SF3407

Workers' Compensation Advisory Council recommendations adoption

MN HF3228

Workers' Compensation Advisory Council recommendations adopted.

LA HB568

Provides that the regulation of therapeutic cannabis be placed under the authority of the Louisiana Department of Health (EG DECREASE GF EX See Note)

CA SB727

Labor-related liabilities: direct contractor.